The first enantioselective reduction of 2-substituted cyclic imines to the corresponding amines (pyrrolidines, piperidines, and azepines) by imine reductases (IREDs) in non-conventional solvents is reported. The best results were obtained in a glycerol/phosphate buffer 1 : 1 mixture, in which heterocyclic amines were produced with full conversions (>99 %), moderate to good yields (22-84 %) and excellent S-enantioselectivities (up to >99 % ee). Remarkably, the process can be performed at a 100 mM substrate loading, which, for the model compound, means a concentration of 14.5 g L-1. A fed-batch protocol was also developed for a convenient scale-up transformation, and one millimole of substrate 1 a was readily converted into 120 mg of enantiopure amine (S)-2 a with a remarkable 80 % overall yield. This aspect strongly contributes to making the process potentially attractive for large-scale applications in terms of economic and environmental sustainability for a good number of substrates used to produce enantiopure cyclic amines of high pharmaceutical interest.

Asymmetric Reduction of Cyclic Imines by Imine Reductase Enzymes in Non‐Conventional Solvents

Arnodo, Davide;De Nardi, Federica;Parisotto, Stefano;De Nardo, Eugenio;Cananà, Stefania;Blangetti, Marco;Prandi, Cristina
2024-01-01

Abstract

The first enantioselective reduction of 2-substituted cyclic imines to the corresponding amines (pyrrolidines, piperidines, and azepines) by imine reductases (IREDs) in non-conventional solvents is reported. The best results were obtained in a glycerol/phosphate buffer 1 : 1 mixture, in which heterocyclic amines were produced with full conversions (>99 %), moderate to good yields (22-84 %) and excellent S-enantioselectivities (up to >99 % ee). Remarkably, the process can be performed at a 100 mM substrate loading, which, for the model compound, means a concentration of 14.5 g L-1. A fed-batch protocol was also developed for a convenient scale-up transformation, and one millimole of substrate 1 a was readily converted into 120 mg of enantiopure amine (S)-2 a with a remarkable 80 % overall yield. This aspect strongly contributes to making the process potentially attractive for large-scale applications in terms of economic and environmental sustainability for a good number of substrates used to produce enantiopure cyclic amines of high pharmaceutical interest.
2024
17
3 articolo e202301243
1
8
https://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/cssc.202301243
asymmetric reduction; biocatalysis; enantioselective; non-conventional solvents; sustainable chemistry
Arnodo, Davide; De Nardi, Federica; Parisotto, Stefano; De Nardo, Eugenio; Cananà, Stefania; Salvatico, Federica; De Marchi, Elisa; Scarpi, Dina; Blangetti, Marco; Occhiato, Ernesto G.; Prandi, Cristina
File in questo prodotto:
File Dimensione Formato  
Manuscript.pdf

Accesso riservato

Descrizione: preprint
Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 941.43 kB
Formato Adobe PDF
941.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
ChemSusChem2023.pdf

Accesso aperto

Descrizione: licenza CC BY 4.0
Tipo di file: PDF EDITORIALE
Dimensione 1.81 MB
Formato Adobe PDF
1.81 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1959251
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact